Քենիա -
անգլերեն -
Pharmacy and Poisons Board
abacavir sulfate /lamivudine tablets 600 mg/300 mg film-coated tablet
mylan laboratories limited c/o. surgilinks ltd mylan laboratories limited, plot no.564/a/22, - abacavir sulfate and lamivudine - film-coated tablet - abacavir sulfate 600mg / lamivudine 300mg - lamivudine and abacavir
Քենիա -
անգլերեն -
Pharmacy and Poisons Board
abacavir sulfate and lamivudine tablets for oral tablet for oral suspension
abacavir sulfate and lamivudine tablets for oral… - tablet for oral suspension - abacavir sulfate usp equivalent to abacavir… - lamivudine and abacavir
Քենիա -
անգլերեն -
Pharmacy and Poisons Board
abacavir sulfate usp and lamivudine usp film-coated tablet
aurobindo pharma ltd aurobindo - abacavir sulfate usp and lamivudine usp - film-coated tablet - abacavir sulfate 600 mg and lamivudine 300 mg - lamivudine and abacavir
Մալթա -
անգլերեն -
Medicines Authority
abacavir/lamivudine actavis coated tablets 600mg/300mg
actavis group ptc ehf - abacavir; lamivudine - film-coated tablet - abacavir 600 mg; lamivudine 300 mg - antivirals for systemic use
Մալթա -
անգլերեն -
Medicines Authority
abacavir/lamivudine teva tablet, film coated 600mg/300mg
teva b.v. swensweg 5, 2031 ga haarlem, netherlands - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use
Մալթա -
անգլերեն -
Medicines Authority
abacavir accord 300 mg film-coated tablets
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use
Իռլանդիա -
անգլերեն -
HPRA (Health Products Regulatory Authority)
abacavir accord 300 mg film-coated tablets
accord healthcare ireland ltd. - abacavir - film-coated tablet - 300 milligram(s) - abacavir
Մալթա -
անգլերեն -
Medicines Authority
abacavir/lamivudine accord healthcare 600mg/300mg film-coated tablets
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use
Ավստրալիա -
անգլերեն -
Department of Health (Therapeutic Goods Administration)
abacavir/lamivudine 600/300 apotex abacavir 600mg (as sulfate) and lamivudine 300mg tablets blister pack
apotex pty ltd - abacavir sulfate,lamivudine -
Ամերիկայի Միացյալ Նահանգներ -
անգլերեն -
NLM (National Library of Medicine)
abacavir, lamivudine and zidovudine- abacavir , lamivudine and zidovudine tablet
lupin pharmaceuticals, inc. - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s), abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - lamivudine 150 mg - abacavir, lamivudine and zidovudine tablet is indicated in combination with other antiretrovirals or alone for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. limitations of use: - limited data exist on the use of abacavir, lamivudine and zidovudine tablets alone in patients with higher baseline viral load levels (greater than 100,000 copies per ml) [see clinical studies (14)] . abacavir, lamivudine and zidovudine tablets are contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)]. - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)], lamivudine, or zidovudine. - with moderate or severe hepatic impairment [see use in specific populations (8.7)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir, lamivudine and zidovudine tablets during pregnancy. healthcare providers are encouraged to register patients